Danish scientists uncovered compelling evidence that a significant percentage of the batches of the Pfizer-BioNTech COVID-19 vaccine distributed in the EU likely consisted of placebos — and the non-placebo batches demonstrated higher-than-normal severe adverse events in recipients, prompting the researchers to call for further investigation.